RATIONALE: Current understanding of the molecular regulation of lung development is limited and derives mostly from animal studies. OBJECTIVES: To define global patterns of gene expression during human lung development. METHODS: Genome-wide expression profiling was used to measure the developing lung transcriptome in RNA samples derived from 38 normal human lung tissues at 53 to 154 days post conception. Principal component analysis was used to characterize global expression variation and to identify genes and bioontologic attributes contributing to these variations. Individual gene expression patterns were verified by quantitative reverse transcriptase-polymerase chain reaction analysis. MEASUREMENTS AND MAIN RESULTS: Gene expression analysis identified attributes not previously associated with lung development, such as chemokine-immunologic processes. Lung characteristics attributes (e.g., surfactant function) were observed at an earlier-than-anticipated age. We defined a 3,223 gene developing lung characteristic subtranscriptome capable of describing a majority of the process. In gene expression space, the samples formed a time-contiguous trajectory with transition points correlating with histological stages and suggesting the existence of novel molecular substages. Induction of surfactant gene expression characterized a pseudoglandular "molecular phase" transition. Individual gene expression patterns were independently validated. We predicted the age of independent human lung transcriptome profiles with a median absolute error of 5 days, supporting the validity of the data and modeling approach. CONCLUSIONS: This study extends our knowledge of key gene expression patterns and bioontologic attributes underlying early human lung developmental processes. The data also suggest the existence of molecular phases of lung development.
RATIONALE: Current understanding of the molecular regulation of lung development is limited and derives mostly from animal studies. OBJECTIVES: To define global patterns of gene expression during human lung development. METHODS: Genome-wide expression profiling was used to measure the developing lung transcriptome in RNA samples derived from 38 normal human lung tissues at 53 to 154 days post conception. Principal component analysis was used to characterize global expression variation and to identify genes and bioontologic attributes contributing to these variations. Individual gene expression patterns were verified by quantitative reverse transcriptase-polymerase chain reaction analysis. MEASUREMENTS AND MAIN RESULTS: Gene expression analysis identified attributes not previously associated with lung development, such as chemokine-immunologic processes. Lung characteristics attributes (e.g., surfactant function) were observed at an earlier-than-anticipated age. We defined a 3,223 gene developing lung characteristic subtranscriptome capable of describing a majority of the process. In gene expression space, the samples formed a time-contiguous trajectory with transition points correlating with histological stages and suggesting the existence of novel molecular substages. Induction of surfactant gene expression characterized a pseudoglandular "molecular phase" transition. Individual gene expression patterns were independently validated. We predicted the age of independent human lung transcriptome profiles with a median absolute error of 5 days, supporting the validity of the data and modeling approach. CONCLUSIONS: This study extends our knowledge of key gene expression patterns and bioontologic attributes underlying early human lung developmental processes. The data also suggest the existence of molecular phases of lung development.
Authors: Alvin T Kho; Soumyaroop Bhattacharya; Brigham H Mecham; Jungha Hong; Isaac S Kohane; Thomas J Mariani Journal: Am J Respir Cell Mol Biol Date: 2008-07-29 Impact factor: 6.914
Authors: Vrushank Davé; Tawanna Childs; Yan Xu; Machiko Ikegami; Valérie Besnard; Yutaka Maeda; Susan E Wert; Joel R Neilson; Gerald R Crabtree; Jeffrey A Whitsett Journal: J Clin Invest Date: 2006-09-21 Impact factor: 14.808
Authors: Carrie V Breton; Hyang-Min Byun; Made Wenten; Fei Pan; Allen Yang; Frank D Gilliland Journal: Am J Respir Crit Care Med Date: 2009-06-04 Impact factor: 21.405
Authors: Tanya V Kalin; I-Ching Wang; Lucille Meliton; Yufang Zhang; Susan E Wert; Xiaomeng Ren; Jonathan Snyder; Sheila M Bell; Lloyd Graf; Jeffrey A Whitsett; Vladimir V Kalinichenko Journal: Proc Natl Acad Sci U S A Date: 2008-11-25 Impact factor: 11.205
Authors: Soumyaroop Bhattacharya; Diana Go; Daria L Krenitsky; Heidi L Huyck; Siva Kumar Solleti; Valerie A Lunger; Leon Metlay; Sorachai Srisuma; Susan E Wert; Thomas J Mariani; Gloria S Pryhuber Journal: Am J Respir Crit Care Med Date: 2012-06-21 Impact factor: 21.405
Authors: Alvin T Kho; Divya Chhabra; Sunita Sharma; Weiliang Qiu; Vincent J Carey; Roger Gaedigk; Carrie A Vyhlidal; J Steven Leeder; Kelan G Tantisira; Scott T Weiss Journal: Am J Respir Cell Mol Biol Date: 2016-06 Impact factor: 6.914
Authors: Alvin T Kho; Kaifeng Liu; Gary Visner; Thomas Martin; Francis Boudreault Journal: Am J Physiol Lung Cell Mol Physiol Date: 2013-08-30 Impact factor: 5.464
Authors: Ruggero Spadafora; Junjie Lu; Radhika S Khetani; Cheng Zhang; Aimee Iberg; Hu Li; Yang Shi; Paul H Lerou Journal: Am J Respir Crit Care Med Date: 2018-10-01 Impact factor: 21.405
Authors: Soula Danopoulos; Matthew E Thornton; Brendan H Grubbs; Mark R Frey; David Warburton; Saverio Bellusci; Denise Al Alam Journal: J Pathol Date: 2018-12-13 Impact factor: 7.996
Authors: Dandi Qiao; Christoph Lange; Terri H Beaty; James D Crapo; Kathleen C Barnes; Michael Bamshad; Craig P Hersh; Jarrett Morrow; Victor M Pinto-Plata; Nathaniel Marchetti; Raphael Bueno; Bartolome R Celli; Gerald J Criner; Edwin K Silverman; Michael H Cho Journal: Am J Respir Crit Care Med Date: 2016-06-15 Impact factor: 21.405